The First Organometallic Selective Estrogen Receptor Modulators (SERMs) and Their Relevance to Breast Cancer

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|11|18|2505-2517

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.11, Iss.18, 2004-09, pp. : 2505-2517

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Discovery and Development of Selective Estrogen Receptor Modulators (SERMs) for Clinical Practice

By  

Current Clinical Pharmacology, Vol. 8, Iss. 2, 2013-01 ,pp. : 135-155

Bentham Science Publishers

Access to resources Recommend Favorite

Selective Estrogen Receptor Modulators (SERMs): Effects on Multiple Organ Systems

By  

Current Medicinal Chemistry, Vol. 7, Iss. 5, 2000-05 ,pp. : 577-584

Bentham Science Publishers

Access to resources Recommend Favorite

Comparative Tolerability of First-Generation Selective Estrogen Receptor Modulators in Breast Cancer Treatment and Prevention

By Curtis M.G.  

Drug Safety, Vol. 24, Iss. 14, 2001-01 ,pp. : 1039-1053

Adis International

Access to resources Recommend Favorite

Selective Estrogen Receptor Modulators and Aromatase Inhibitors for Breast Cancer Chemoprevention

By  

Current Drug Targets, Vol. 12, Iss. 13, 2011-12 ,pp. : 1874-1887

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Advances in Selective Estrogen Receptor Modulators for Breast Cancer

By  

Mini Reviews in Medicinal Chemistry, Vol. 9, Iss. 10, 2009-09 ,pp. : 1191-1201

Bentham Science Publishers

Access to resources Recommend Favorite